The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zoledronic acid. The risk or severity of adverse effects can be increased when Moexipril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Naproxen is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Indenolol. Ibuprofen may increase the neuroexcitatory activities of Enoxacin. Ibuprofen may decrease the antihypertensive activities of Oxprenolol. The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Grepafloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Andrographolide. The metabolism of Ibuprofen can be decreased when combined with Tolbutamide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Equilin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Anisodamine. Ibuprofen may increase the nephrotoxic activities of Mesalazine. The risk or severity of adverse effects can be increased when Perindopril is combined with Ibuprofen. The metabolism of Ibuprofen can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alclofenac. The risk or severity of adverse effects can be increased when Forasartan is combined with Ibuprofen. The therapeutic efficacy of Sulprostone can be decreased when used in combination with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Pioglitazone. Ibuprofen may decrease the antihypertensive activities of Bucindolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Beclomethasone dipropionate. Ibuprofen may increase the neuroexcitatory activities of Trovafloxacin. The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Androstenedione. The metabolism of Ibuprofen can be decreased when combined with Valproic Acid. Ibuprofen may increase the anticoagulant activities of Troxerutin. The risk or severity of adverse effects can be increased when Tasosartan is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Bucillamine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Aldosterone. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Omacetaxine mepesuccinate. The risk or severity of adverse effects can be increased when Captopril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rimexolone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nimesulide. The metabolism of Ibuprofen can be decreased when combined with Fluvastatin. Ibuprofen may decrease the excretion rate of Sisomicin which could result in a higher serum level. The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Certoparin. The risk or severity of adverse effects can be increased when Olmesartan is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fenbufen. Ibuprofen may decrease the excretion rate of Zoptarelin doxorubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Icatibant. The metabolism of Ibuprofen can be decreased when combined with Nilotinib. Ibuprofen may decrease the antihypertensive activities of Nebivolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flurandrenolide. Ibuprofen may increase the neuroexcitatory activities of Temafloxacin. Ibuprofen may increase the anticoagulant activities of Dextran 75. Ibuprofen may decrease the antihypertensive activities of Atenolol. The risk or severity of adverse effects can be increased when Eprosartan is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Celecoxib. The metabolism of Ibuprofen can be decreased when combined with Cimetidine. The risk or severity of adverse effects can be increased when Saprisartan is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Acebutolol. The metabolism of Ibuprofen can be increased when combined with Primidone. The risk or severity of adverse effects can be increased when Valdecoxib is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Acenocoumarol. Sarilumab may increase the immunosuppressive activities of Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Tranylcypromine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tiaprofenic acid. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Duvelisib. Ibuprofen may decrease the antihypertensive activities of Amiloride. Colesevelam can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Adapalene is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Amiodarone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Mometasone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Technetium Tc-99m medronate. Ibuprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Topiramate. The therapeutic efficacy of Alprostadil can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Quinapril is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Pantoprazole. Ibuprofen may increase the anticoagulant activities of Nafamostat. Ibuprofen may increase the anticoagulant activities of Phenprocoumon. Ibuprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Zucapsaicin. Ibuprofen may increase the anticoagulant activities of Bivalirudin. The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Pazufloxacin. Ibuprofen may increase the neuroexcitatory activities of Norfloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Indoprofen. The risk or severity of adverse effects can be increased when Etodolac is combined with Ibuprofen. The serum concentration of Ibuprofen can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Methylprednisolone. The metabolism of Ibuprofen can be increased when combined with Rifampicin. The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Ibuprofen. The serum concentration of Ibuprofen can be increased when it is combined with Ceritinib. Ibuprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Serrapeptase. The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ibuprofen. The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with E-6201. The serum concentration of Pralatrexate can be increased when it is combined with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Levofloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etidronic acid. Ibuprofen may decrease the antihypertensive activities of Bevantolol. Ibuprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Lumiracoxib. The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortisone acetate. The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Ibuprofen. The serum concentration of Imatinib can be decreased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Carbaspirin calcium. Ibuprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level. Ibuprofen may increase the neuroexcitatory activities of Prulifloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with 5-androstenedione. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Paramethasone. The metabolism of Ibuprofen can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Bupranolol. The metabolism of Ibuprofen can be decreased when combined with Esomeprazole. Colestipol can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Equilenin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Estrone sulfate. Ibuprofen may increase the anticoagulant activities of Heparin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etoricoxib. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Indobufen. Ibuprofen may decrease the excretion rate of Amrubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Formestane. The risk or severity of adverse effects can be increased when Talniflumate is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Protein S human. Ibuprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Parthenolide. Ibuprofen may increase the neuroexcitatory activities of Pefloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Oleoyl-estrone. The metabolism of Ibuprofen can be decreased when combined with Midostaurin. The metabolism of Ibuprofen can be decreased when combined with Dosulepin. Ibuprofen may increase the anticoagulant activities of Citric Acid. The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ibuprofen.